Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • LENALIDOMIDE IN COMBINATION WITH DEXAMETHASONE IN ELDERLY PATIENTS WITH ADVANCED, RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND RENAL FAILURE

    Patrizia Tosi
    e2013037
    2013-06-03
    https://doi.org/10.4084/mjhid.2013.037
    1337
    PDF: 914
    HTML: 1283
    fig 1A: 181
    figure1B: 153
  • CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH

    Lisa Pieri, Paola Guglielmelli, Alessandro Maria Vannucchi
    e2010017
    2010-06-18
    https://doi.org/10.4084/mjhid.2010.017
    1710
    PDF: 749
    HTML: 2347
  • Community-acquired Carbapenem-resistant Escherichia coli Bacteremia Complicated by c: A Case Report

    Yu Chen, Jin Zhang, wenqiang kong
    e2026005
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.005
    576
    PDF: 463
    HTML: 97
  • Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio

    Dr. Enrica A. Martino, Dr. G. Mele, Dr. F. Morabito, Dr. M. Gentile, Dr. E. Vigna
    e2025006
    2024-12-31
    https://doi.org/10.4084/MJHID.2025.006
    2205
    PDF: 1619
    HTML: 317
  • CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.

    Vincenzo De Sanctis
    e2020006
    2020-01-01
    https://doi.org/10.4084/mjhid.2020.006
    4310
    PDF: 1535
    HTML: 460
  • TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL

    Giorgia Sulis, Alberto Roggi, Alberto Matteelli, Mario C. Raviglione
    e2014070
    2014-10-27
    https://doi.org/10.4084/mjhid.2014.070
    7104
    PDF: 4000
    HTML: 24897
  • TYROSINE KINASE INHIBITORS AND PREGNANCY

    Elisabetta Abruzzese, Malgorzata Monika Trawinska, Paolo De Fabritiis, Alessio Pio Perrotti
    e2014028
    2014-04-07
    https://doi.org/10.4084/mjhid.2014.028
    3659
    PDF: 1668
    HTML: 2683
  • Pseudo-differentiation syndrome

    Dina Khalaf, Fathi Jehani
    e2011061
    2011-12-15
    https://doi.org/10.4084/mjhid.2011.061
    1394
    PDF: 673
    HTML: 10852
    Figure 1: peripheral blood showing myeloblasts with auer rods: 121
    Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 106
    Figure 3: CXR showing pulmonary infiltartes with consolidation: 137
    Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 118
    Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 119
  • Prognostic Impact Of Baseline Immunologic Profile In Aggressive B-cell Non-Hodgkin’s Lymphomas

    Safaa M. Ramadan
    e2021018
    2021-02-26
    https://doi.org/10.4084/mjhid.2021.018
    1133
    PDF: 388
    HTML: 237
  • Primary pulmonary Hodgkin Lymphoma simulating a mediastinal tumour: an uncommon occurrence.

    Stefano Fratoni, Pasquale Niscola, Elisabetta Abruzzese, Malgorzata Monika Trawinska, Edoardo Mercadante, Andrea Casullo, Paolo de Fabritiis, Alessio Perrotti, Giuseppe Santeusanio
    e2013013
    2013-02-16
    https://doi.org/10.4084/mjhid.2013.013
    1355
    PDF: 716
    HTML: 1967
  • ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children

    Ilaria Lazzareschi, Elena Rossi, Antonietta Curatola, Giovanna Capozio, Luca Benacquista, Ludovica Iezzi, Donato Rigante
    e2022008
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.008
    2334
    PDF: 1178
    HTML: 652
  • Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia

    Massimo Breccia, Gioia Colafigli, Luisa Quattrocchi, elisabetta abruzzese, giuliana alimena
    e2016016
    2016-02-20
    https://doi.org/10.4084/mjhid.2016.016
    2935
    PDF: 698
    HTML: 1941
    figure 1: 178
    figure 2: 183
  • ROLE OF STEM CELL FACTOR IN THE REACTIVATION OF HUMAN FETAL HEMOGLOBIN

    Marco Gabbianelli, Ugo Testa
    e2009009
    2009-11-12
    1167
    PDF: 483
    HTML: 4497
  • MULTIPARAMETRIC FLOW CYTOMETRY REFINES RISK STRATIFICATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS

    Francesca Fazio, Gianfranco Lapietra, Maria Zaira Limongi, Stefania Intoppa, Maria Laura Milani, Alfonso Piciocchi, Maurizio Martelli, Anna Guarini, Robin Foà, Maria Stefania De Propris, Maria Teresa Petrucci
    e2023047
    2023-08-29
    https://doi.org/10.4084/MJHID.2023.047
    1033
    PDF: 733
    HTML: 279
  • JC Virus leuko-encephalopathy in reduced intensity conditioning cord blood transplant recipient.

    jean elcheikh
    e2012043
    2012-06-20
    https://doi.org/10.4084/mjhid.2012.043
    1134
    PDF: 845
    HTML: 10942
  • Sarcoid-like Reactions in Hodgkin Lymphoma Treated with Pembrolizumab: a Case Report

    Pier Luigi Zinzani, Flavia Salvatore, Beatrice Casadei, Camilla Mazzoni, Marianna Gentilini, Giulia Gabrielli, Lisa Argnani
    e2026052
    2026-06-30
    https://doi.org/10.4084/MJHID.2026.052
    256
    PDF: 102
    HTML: 26
  • In Vivo Emergence of UL56 C325Y Cytomegalovirus Resistance to Letermovir in a Patient with Acute Myeloid Leukemia after Hematopoietic Cell Transplantation

    Jochen J Frietsch, Detlef Michel, Thomas Stamminger, Friederike Hunstig, Sebastian Birndt, Ulf Schnetzke, Sebastian Scholl, Andreas Hochhaus, Inken Hilgendorf
    e2019001
    2019-01-01
    https://doi.org/10.4084/mjhid.2019.001
    2360
    PDF: 1455
    HTML: 280
  • NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?

    Alessandro Corso, Silvia Mangiacavalli
    e2017053
    2017-08-18
    https://doi.org/10.4084/mjhid.2017.053
    3286
    PDF: 1724
    HTML: 1099
  • PROGNOSTIC VALUE OF PROTEASE ACTIVATED RECEPTOR-1 IN EGYPTIAN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA

    Adel Abd Elhaleim Hagag
    e2014029
    2014-04-06
    https://doi.org/10.4084/mjhid.2014.029
    1364
    PDF: 801
    HTML: 2267
  • BONE MARROW ABONRMALITIES IN HIV INFECTION

    Sharad Antiram Dhurve
    e2013033
    2013-06-03
    https://doi.org/10.4084/mjhid.2013.033
    1910
    PDF: 1148
    HTML: 1767
  • EPIDEMIOLOGY AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN LATIN AMERICA

    Eduardo Magalhães Rego, Rafael Henriques Jácomo
    e2011049
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.049
    2722
    PDF: 1052
    HTML: 2569
  • ROLE OF COMORBIDITIES IN OPTIMIZING DECISION-MAKING FOR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

    Mohamed L. Sorror, Rainer F. Storb
    e2010015
    2010-06-08
    https://doi.org/10.4084/mjhid.2010.015
    1020
    PDF: 644
    HTML: 2235
  • KINETICS AND ROLE OF PANCREATIC STONE PROTEIN AND MIDREGIONAL PROADRENOMEDULLIN AS PREDICTORS OF SEPSIS AND BACTEREMIA IN CHILDREN WITH HAEMATOLOGICAL MALIGNANCIES.

    Vasiliki Antari, Lemonia Skoura, Athanasios Tragiannidis, Emmanuel Hatzipantelis, Vasiliki-Rengina Tsinopoulou, Konstantina Papakonstantinou, Efthimia Protonotariou, Assimina Galli-Tsinopoulou
    e2023065
    2023-10-30
    https://doi.org/10.4084/MJHID.2023.065
    927
    PDF: 749
    HTML: 127
  • Parasitic hypereosinophilia in childhood: a diagnostic challenge

    Roberto Antonucci, Nadia Vacca, Giulia Boz, Cristian Locci, Rosanna Mannazzu, Claudio Cherchi, Giacomo Lai, Claudio Fozza
    e2018034
    2018-05-01
    https://doi.org/10.4084/mjhid.2018.034
    2611
    PDF: 822
    HTML: 307
    Figure 1: 173
  • USP9X INCREASED TUMOR ANGIOGENESIS IN MANTLE CELL LYMPHOMA BY UPREGULATION OF CCND1- MEDIATED SOX11

    Gang Huang, Jianjun Liao, Mingli Wang, Yali Huang, Mingjie Tang, Yanyan Hao
    e2022048
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.048
    867
    PDF: 714
    HTML: 215
  • COMPARISON OF THREE DISTINCT PROPHYLACTIC AGENTS AGAINST INVASIVE FUNGAL INFECTIONS IN PATIENTS UNDERGOING HAPLO-IDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION AND POST-TRANSPLANT CYCLOPHOSPHAMIDE

    Jean Elcheikh
    e2015048
    2015-08-21
    https://doi.org/10.4084/mjhid.2015.048
    1929
    PDF: 1025
    HTML: 1356
  • HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients

    Wenshan Yang, Wei Dong
    e2025029
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.029
    2550
    PDF: 1018
    HTML: 169
    Suppl. Files: 517
  • BACTERIAL BLOOD STREAM INFECTIONS NEGATIVELY IMPACT ON OUTCOME OF PATIENTS TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION: 6 YEARS SINGLE-CENTRE EXPERIENCE

    Michele Malagola
    e2017036
    2017-06-20
    https://doi.org/10.4084/mjhid.2017.036
    2461
    PDF: 844
    HTML: 1068
  • ANORECTAL COMPLICATIONS DURING NEUTROPENIC PERIOD IN PATIENTS WITH HEMATOLOGIC DISEASES

    Soner Solmaz
    e2016019
    2016-03-01
    https://doi.org/10.4084/mjhid.2016.019
    3052
    PDF: 986
    HTML: 1570
  • THE BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS INFECTION.

    Giovanni Delogu, Michela Sali, Giovanni Fadda
    e2013070
    2013-11-15
    https://doi.org/10.4084/mjhid.2013.070
    10724
    PDF: 6437
    HTML: 21817
  • THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA

    Davide Rossi, Marco Fangazio, Gianluca Gaidano
    e2012076
    2012-11-13
    https://doi.org/10.4084/mjhid.2012.076
    2290
    PDF: 898
    HTML: 2007
    Fig 1 Rossi: 189
  • Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia

    Zhan Su, Feng Wang
    e2025063
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.063
    897
    PDF: 502
    HTML: 170
    Suppl. Files: 332
  • IS IT SAFE AND COST SAVING TO DEFER THE CD4+ CELL COUNT MONITORING IN STABLE PATIENTS ON ART WITH MORE THAN 350 OR 500 CELLS/µL?

    Benedetto Maurizio Celesia, Dr., Andrea Marino, Dr., Rosa Fontana del Vecchio, Dr., Roberto Bruno, Dr., Filippo Palermo, Professor, Maria Gussio, Dr., Giuseppe Nunnari, Professor, Bruno Cacopardo, Professor
    e2019063
    2019-10-30
    https://doi.org/10.4084/mjhid.2019.063
    1468
    PDF: 763
    HTML: 224
  • Leukocyte derived chemotaxin 2 (ALECT2) amyloidosis

    Uday P Kulkarni, Anna Valson, Anila Korula, Vikram Mathews
    e2015043
    2015-07-01
    https://doi.org/10.4084/mjhid.2015.043
    1622
    PDF: 787
    HTML: 1311
  • Systemic granulomatous reaction secondary to treatment of bladder cancer with Bacillus Calmette-Guerin

    Caterina Giovanna Valentini, Valentina Bozzoli, Anna Rita Larici, Luigi Maria Larocca, Giovanni Delogu, Giuseppe Leone, Livio Pagano
    e2012040
    2012-06-18
    https://doi.org/10.4084/mjhid.2012.040
    1941
    PDF: 670
    HTML: 19261
  • IMPACT OF QUALITATIVE AND QUANTITATIVE IMMUNOPARESIS ON EARLY INFECTION RISK IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA Immunoparesis and early infection risk in myeloma

    Hongfeng Wang, Jianbin Chen
    e2026062
    2026-06-30
    https://doi.org/10.4084/MJHID.2026.062
    97
    PDF: 98
    HTML: 22
  • PERPHERAL BLOOD CELL MITOCHONDRIAL DYSFUNCTION IN MYELODYSPLASTIC SYNDROMECAN BE IMPROVED BY A COMBINATION OF COENZYME Q10 AND CARNITINE Blood cell mitochondrial dysfunction in myelodysplastic syndrome

    Kalman Filanovsky, Michal Haran, Vita Mirkin, Andrei Braester, Olga Shevetz, Anfisa Stanevsky, Erica Sigler, Ekaterina Votinov, Yehudit Zalzman-Amir, Alain Berrebi, Atan Gross, Lev Shvidel
    e2020072
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.072
    1142
    PDF: 782
    HTML: 329
  • SPECTRUM AND IMMUNOPHENOTYPIC PROFILE OF ACUTE LEUKEMIA: A TERTIARY CENTER FLOW CYTOMETRY EXPERIENCE

    Nishit Gupta, Ravikiran Pawar, Sambhunath Banerjee, Subhajit Brahma, Asish Rath, Sundar Shewale, Mayur Parihar, Manish Singh, Arun SR, Shekhar Krishnan, Arpita Bhattacharyya, Anirban Das, Jeevan Kumar, Saurabh Bhave, Vivek Radhakrishnan, Reena nair, Mammen Chandy, Neeraj Arora, Deepak Kumar Mishra
    e2019017
    2019-02-26
    https://doi.org/10.4084/mjhid.2019.017
    3278
    PDF: 1644
    HTML: 440
  • THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE

    Lucrezia Laterza, Gianenrico Rizzatti, Eleonora Gaetani, Patrizia Chiusolo, Antonio Gasbarrini
    e2016025
    2016-05-01
    https://doi.org/10.4084/mjhid.2016.025
    6375
    PDF: 2142
    HTML: 14032
    Untitled: 207
    figure: 191
  • SYSTEMIC MASTOCYTOSIS: MOLECULAR LANDSCAPE AND IMPLICATIONS FOR TREATMENT

    Cecilia Monaldi, Sara De Santis, Manuela Mancini, Samantha Bruno, Michele Cavo, Simona Soverini
    e2021046
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.046
    1429
    PDF: 746
    HTML: 308
  • COMPARISON OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS IN HEALTHY COMMUNITY HOSPITAL VISITORS[CA-MRSA] AND HOSPITAL STAFF [HA-MRSA]

    Nirmal A Pathare, Anil Pathare
    e2015053
    2015-10-07
    https://doi.org/10.4084/mjhid.2015.053
    1872
    PDF: 1206
    HTML: 1550
  • TYROSINE KINASE INHIBITORS AND INTERFERON

    Maria Dimou, Panagiotis Panagiotidis
    e2014006
    2014-01-02
    https://doi.org/10.4084/mjhid.2014.006
    2894
    PDF: 1454
    HTML: 3058
    Cover Letter: 213
  • PROGNOSTIC SIGNIFICANCE OF TRANSCRIPT-TYPE BCR/ABL1 IN CHRONIC MYELOID LEUKEMIA

    matteo molica, elisabetta abruzzese, massimo breccia
    e2020062
    2020-09-12
    https://doi.org/10.4084/mjhid.2020.062
    3865
    PDF: 1620
    HTML: 677
  • MOLECULAR HETEROGENEITY IN ACUTE PROMYELOCYTIC LEUKEMIA - A SINGLE CENTRE EXPERIENCE FROM INDIA

    Nikhil Rabade, Goutham Raval, Shruti Chaudhary, PG Subramanian, Rohan Kodgule, Swapnali Joshi, Prashant Tembhare, Hasmukh Jain, Manju Sengar, Syed Hasan K, Pratibha Amare Kadam, Dhanalaxmi Shetty, Gaurav Narula, Shripad Banavali, Sumeet Gujral, Nikhil Patkar
    e2018002
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.002
    3676
    PDF: 1217
    HTML: 1106
  • IS THE INCIDENCE TREND OF HEPARIN-INDUCED THROMBOCYTOPENIA DECREASED BY THE INCREASED USE OF LOW-MOLECULAR-WEIGHT-HEPARIN?

    Fahad Al-Eidan
    e2015029
    2015-04-19
    https://doi.org/10.4084/mjhid.2015.029
    1700
    PDF: 830
    HTML: 1488
  • Skin Involvement in Primary Systemic Amyloidosis

    susheel kumar
    e2013005
    2013-01-02
    https://doi.org/10.4084/mjhid.2013.005
    1667
    PDF: 902
    HTML: 4388
    Figure 1. Photographs showing (a) enlarged tongue with (b) teeth marks over the lateral margin and (c, d) multiple, papular lesions over lower chest wall: 184
    Figure 2. Microphotograph showing pink eosinophilic homogenous material in the dermis, H&E X 20: 158
    Figure 3. Pink eosinophilic material showing pale orange positivity with Congo red stain: 181
  • THE TREATMENT OF MULTIPLE MYELOMA PATIENTS NOT ELIGIBLE FOR ASCT

    Paul Richardson, Jacob Laubach, Anuj Mahindra, Constantine Mitsiades, Robert Schlossman, Irene Ghobrial, Teru Hideshima, Noopur Raje, Nikhil Munshi, Kenneth Anderson
    e2010009
    2010-05-03
    https://doi.org/10.4084/mjhid.2010.009
    1139
    PDF: 728
    HTML: 621
  • MIR-140 TARGETS LNCRNA DNAJC3-AS1 TO SUPPRESS CELL PROLIFERATION IN ACUTE MYELOID LEUKEMIA AML proliferation and MIR-140 LNCRNA DNAJC3-AS1 target.

    Hong Li, Kehong Bi, Saran Feng, Yan Yan Wang, Chuansheng Zhu
    e2022005
    2022-01-01
    https://doi.org/10.4084/mjhid.2022.005
    1244
    PDF: 613
    HTML: 225
  • EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN

    Massimiliano Salati, Marina Cesaretti, Matteo Macchia, Mufid El Mistiri, Massimo Federico
    e2014048
    2014-06-29
    https://doi.org/10.4084/mjhid.2014.048
    3587
    PDF: 1235
    HTML: 5006
    Incidence age-standardized rates for HL across the Mediterranean basin: 210
  • Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES

    Giuseppe Leone, Luigi Maria Larocca, Eligio Pizzigallo
    e2009001
    2009-06-22
    3358
    PDF: 588
    HTML: 674
401 - 450 of 473 items << < 4 5 6 7 8 9 10 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.